41
In band
Moving averages
SMA 200$97.80-9.85%
Company profile
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$24.08B
P/E ratioNone
EPS$-7.83
Beta1.252
Dividend yield0.00%
52-week high$124.00
52-week low$79.52
Similar stocks in Biotechnology
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
IBRX
ImmunityBio Inc
RSI 44
TECH
Bio-Techne Corp
RSI 57
BMRN
Biomarin Pharmaceutical Inc
RSI 55
MRNA
Moderna Inc
RSI 57
VKTX
Viking Therapeutics Inc
RSI 48
TARS
Tarsus Pharmaceuticals Inc
RSI 55
ATAI
ATAI Life Sciences N.V.
RSI 62
RSI alerts for BNTX
An email when BNTX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 8:28 PM EDT